Inflammation and cardiovascular diseases

por Wang, Hui, Jing, Zhi-Cheng
Publicado 2020

The limits of oral therapy in pulmonary arterial hypertension management

por Liu, Qian-Qian, Jing, Zhi-Cheng
Publicado 2015

Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension

por Lian, Tian-Yu, Jiang, Xin, Jing, Zhi-Cheng
Publicado 2017

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases

por Zhang, Rui, He, Yang-Yang, Jing, Zhi-Cheng
Publicado 2020

Reply: Homocysteine and Thrombophilia in Pulmonary Hypertension

por Lian, Tian-Yu, Zhou, Yu-Ping, Zhu, Yong-Jian, Guo, Fan, Jing, Zhi-Cheng
Publicado 2022

Up-regulation of hexokinase1 in the right ventricle of monocrotaline induced pulmonary hypertension

por Zhang, Wei-hua, Qiu, Mei-hong, Wang, Xiao-jian, Sun, Kai, Zheng, Yang, Jing, Zhi-cheng
Publicado 2014

Experimental animal models of pulmonary hypertension: Development and challenges

por Wu, Xiao‐Han, Ma, Jie‐Ling, Ding, Dong, Ma, Yue‐Jiao, Wei, Yun‐Peng, Jing, Zhi‐Cheng
Publicado 2022

Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension

por Vizza, Carmine Dario, Sastry, B. K. S., Safdar, Zeenat, Harnisch, Lutz, Gao, Xiang, Zhang, Min, Lamba, Manisha, Jing, Zhi-Cheng
Publicado 2017

Implication of proliferation gene biomarkers in pulmonary hypertension

por Yan, Yi, Jiang, Rong, Yuan, Ping, Wen, Li, Pang, Xiao‐Bin, Jing, Zhi‐Cheng, He, Yang‐Yang, Han, Zhi‐Yan
Publicado 2021

Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL): A Novel Biomarker for Prognostic Assessment and Risk Stratification of Acute Pulmonary Embolism

por Yu, Haixu, Rong, Wei, Yang, Jie, Lu, Jie, Ma, Ke, Liu, Zhuohui, Yuan, Hui, Xu, Lei, Li, Yulin, Jing, Zhi-Cheng, Du, Jie
Publicado 2022

A novel scoring index by Doppler echocardiography for predicting severe pulmonary hypertension due to chronic lung diseases: a cross-sectional diagnostic accuracy study

por Jiang, Rong, Wu, Cheng, Pudasaini, Bigyan, Wang, Lan, Zhao, Qin-Hua, Zhang, Rui, Wu, Wen-Hui, Yuan, Ping, Jing, Zhi-Cheng, Liu, Jin-Ming
Publicado 2017

Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension

por Wang, Lan, Jin, Yuan-Zhe, Zhao, Qin-Hua, Jiang, Rong, Wu, Wen-hui, Gong, Su-Gang, He, Jing, Liu, Jin-Ming, Jing, Zhi-Cheng
Publicado 2017

Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison

por Wang, Chen, Jing, Zhi-Cheng, Huang, Yi-Gao, Zhou, Da-Xin, Liu, Zhi-Hong, Meier, Christian, Nikkho, Sylvia, Curram, John, Zhang, Peng, He, Jian-Guo
Publicado 2016

Alteration of Extracellular Superoxide Dismutase in Idiopathic Pulmonary Arterial Hypertension

por Zhang, Rui, Wang, Lan, Zhao, Qin-Hua, Jiang, Rong, Gong, Su-Gang, Jiang, Xin, Xu, Xi-Qi, He, Yang-Yang, Li, Yuan, Jing, Zhi-Cheng
Publicado 2020

Native T1 Mapping-Based Radiomics for Noninvasive Prediction of the Therapeutic Effect of Pulmonary Arterial Hypertension

por Wang, Yue, Lin, Lu, Li, Xiao, Cao, Jian, Wang, Jian, Jing, Zhi-Cheng, Li, Sen, Liu, Hao, Wang, Xin, Jin, Zheng-Yu, Wang, Yi-Ning
Publicado 2022

Metabolic reprogramming of the urea cycle pathway in experimental pulmonary arterial hypertension rats induced by monocrotaline

por Zheng, Hai-Kuo, Zhao, Jun-Han, Yan, Yi, Lian, Tian-Yu, Ye, Jue, Wang, Xiao-Jian, Wang, Zhe, Jing, Zhi-Cheng, He, Yang-Yang, Yang, Ping
Publicado 2018

Risk stratification and medical therapy of pulmonary arterial hypertension

por Galiè, Nazzareno, Channick, Richard N., Frantz, Robert P., Grünig, Ekkehard, Jing, Zhi Cheng, Moiseeva, Olga, Preston, Ioana R., Pulido, Tomas, Safdar, Zeenat, Tamura, Yuichi, McLaughlin, Vallerie V.
Publicado 2019

Adventitial Cell Atlas of wt (Wild Type) and ApoE (Apolipoprotein E)-Deficient Mice Defined by Single-Cell RNA Sequencing

por Gu, Wenduo, Ni, Zhichao, Tan, Yuan-Qing, Deng, Jiacheng, Zhang, Si-Jin, Lv, Zi-Chao, Wang, Xiao-Jian, Chen, Ting, Zhang, Zhongyi, Hu, Yanhua, Jing, Zhi-Cheng, Xu, Qingbo
Publicado 2019

Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis

por Li, Mengtao, Jing, Zhi-Cheng, Li, Yang, Huo, Yong, Yu, Zaixin, Zhang, Gangcheng, Zhu, Ping, Liu, Jinming, Ji, Qiushang, Wu, Bingxiang, Zhong, Jinhua, Wang, Pingping, Zhu, Wenjing, Zeng, Xiaofeng
Publicado 2020

Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension

por Zhu, Yong-Jian, Zhou, Yu-Ping, Wei, Yun-Peng, Xu, Xi-Qi, Yan, Xin-Xin, Liu, Chao, Zhu, Xi-Jie, Liu, Zi-Yi, Sun, Kai, Hua, Lu, Jiang, Xin, Jing, Zhi-Cheng
Publicado 2021